Sources Reveal Biogen is Exploring Sale of Hemophilia Assets Post author:Sam Post published:April 11, 2016 Post category:BioPharma April 11, 2016By Mark Terry, BioSpace.com Breaking News Staff<BR… Source: BioSpace You Might Also Like Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017 Late-Stage Life Sciences Investment Firm, Aisling Capital, Closes $280M Fund November 1, 2017 SAGE Therapeutics Crashes Hard as Lead Epilepsy Drug Flunks Phase III Test September 11, 2017
Kedrion And Kamada Receive FDA Approval Of KEDRAB For Post-Exposure Prophylaxis Against Rabies Infection August 24, 2017
